Add mortality attribution evaluation
This commit is contained in:
@@ -37,12 +37,12 @@ all-future DeepHealth 模型应被解释为一个基于既往轨迹的未来新
|
||||
|
||||
\section{English}
|
||||
|
||||
\subsection{Model object}
|
||||
\subsection{Model Object}
|
||||
|
||||
For individual \(i\), let \(\mathcal{H}_i(t)\) denote the observed history up to
|
||||
query time \(t\). The all-future model produces
|
||||
\[
|
||||
h_i(t) = f_\theta(\mathcal{H}_i(t)),
|
||||
h_i(t)=f_\theta(\mathcal{H}_i(t)),
|
||||
\]
|
||||
and, for each disease token \(d\) in the modeled disease vocabulary
|
||||
\(\mathcal{D}\), estimates a future first-occurrence risk over a horizon
|
||||
@@ -68,7 +68,7 @@ history itself we know
|
||||
This historical indicator is not learned by the model; it is read directly from
|
||||
the event history.
|
||||
|
||||
\subsection{Masking already occurred diseases}
|
||||
\subsection{Masking Already Occurred Diseases}
|
||||
|
||||
For a disease that has already occurred before or at \(t\), the model output for
|
||||
that disease should not be interpreted as recurrence risk or current disease
|
||||
@@ -77,10 +77,10 @@ should be masked:
|
||||
\[
|
||||
p^{\mathrm{new}}_{i,d}(t,\tau)
|
||||
=
|
||||
\left[1-m_{i,d}(t)\right]p_{i,d}(t,\tau).
|
||||
[1-m_{i,d}(t)]p_{i,d}(t,\tau).
|
||||
\]
|
||||
|
||||
\subsection{Directly supported model-derived quantities}
|
||||
\subsection{Directly Supported Quantities}
|
||||
|
||||
The current model directly supports the following quantities.
|
||||
|
||||
@@ -100,42 +100,64 @@ is the estimated probability of death within the next \(\tau\) years. Death is a
|
||||
terminal endpoint and should not be treated as an ordinary disease burden
|
||||
weight.
|
||||
|
||||
\paragraph{Probability of being alive with no new modeled disease.}
|
||||
Using the model's disease-specific and death risks, one can summarize the
|
||||
probability of no new modeled disease and survival over the next \(\tau\) years:
|
||||
\[
|
||||
S^{\mathrm{all}}_i(t,\tau)
|
||||
=
|
||||
\left[1-p_{i,\mathrm{death}}(t,\tau)\right]
|
||||
\prod_{d\in\mathcal{D}}
|
||||
\left[1-p^{\mathrm{new}}_{i,d}(t,\tau)\right].
|
||||
\]
|
||||
Equivalently, if the model is represented through cumulative hazards
|
||||
\(\Lambda_{i,d}(t,\tau)=-\log[1-p_{i,d}(t,\tau)]\),
|
||||
\[
|
||||
S^{\mathrm{all}}_i(t,\tau)
|
||||
=
|
||||
\exp\left(
|
||||
-\Lambda_{i,\mathrm{death}}(t,\tau)
|
||||
-\sum_{d\in\mathcal{D}}
|
||||
[1-m_{i,d}(t)]\Lambda_{i,d}(t,\tau)
|
||||
\right).
|
||||
\]
|
||||
|
||||
\paragraph{Probability of being alive with no new disease in a specified set.}
|
||||
\paragraph{Future incident disease risk in a specified set.}
|
||||
For any analyst-specified subset of disease tokens \(G\subseteq\mathcal{D}\),
|
||||
the model can summarize future incident risk within that set:
|
||||
\[
|
||||
S^{G}_i(t,\tau)
|
||||
R^G_i(t,\tau)
|
||||
=
|
||||
\left[1-p_{i,\mathrm{death}}(t,\tau)\right]
|
||||
\prod_{d\in G}
|
||||
\left[1-p^{\mathrm{new}}_{i,d}(t,\tau)\right].
|
||||
1-\prod_{d\in G}\left[1-p^{\mathrm{new}}_{i,d}(t,\tau)\right].
|
||||
\]
|
||||
This is a subset-level future disease-free survival summary. If \(G\) is called
|
||||
an organ system, the disease-to-organ grouping is external to the model and
|
||||
must not be described as a learned organ score.
|
||||
This quantity answers: ``What is the model-estimated probability that at least
|
||||
one not-yet-observed disease in \(G\) first occurs within the next \(\tau\)
|
||||
years?'' It does not include death. Mortality risk should be reported
|
||||
separately as \(p_{i,\mathrm{death}}(t,\tau)\).
|
||||
|
||||
\subsection{Historical counts are not model-derived burden}
|
||||
If \(G\) is called an organ system, the disease-to-organ grouping is external to
|
||||
the model and should not be described as a learned organ score.
|
||||
|
||||
\subsection{Model Attribution to Predicted Mortality Risk}
|
||||
|
||||
The model can also be queried for a model-internal attribution of historical
|
||||
disease sets to predicted mortality risk. For a disease set \(G\), define the
|
||||
original mortality risk as
|
||||
\[
|
||||
p_{i,\mathrm{death}}^{\mathrm{orig}}(t,\tau),
|
||||
\]
|
||||
and the risk after deleting historical disease tokens in \(G\) from the input
|
||||
history as
|
||||
\[
|
||||
p_{i,\mathrm{death}}^{(-G)}(t,\tau).
|
||||
\]
|
||||
On the probability scale, the attribution is
|
||||
\[
|
||||
\Delta p^G_i(t,\tau)
|
||||
=
|
||||
p_{i,\mathrm{death}}^{\mathrm{orig}}(t,\tau)
|
||||
-
|
||||
p_{i,\mathrm{death}}^{(-G)}(t,\tau).
|
||||
\]
|
||||
A more stable primary scale is the cumulative-hazard scale:
|
||||
\[
|
||||
\Lambda_{i,\mathrm{death}}(t,\tau)
|
||||
=
|
||||
-\log\left[1-p_{i,\mathrm{death}}(t,\tau)\right],
|
||||
\]
|
||||
\[
|
||||
\Delta \Lambda^G_i(t,\tau)
|
||||
=
|
||||
\Lambda_{i,\mathrm{death}}^{\mathrm{orig}}(t,\tau)
|
||||
-
|
||||
\Lambda_{i,\mathrm{death}}^{(-G)}(t,\tau).
|
||||
\]
|
||||
|
||||
This quantity should be described as model attribution to predicted mortality
|
||||
risk. It is not a causal contribution, not an organ damage score, and not a
|
||||
clinical disease-burden weight. Because diseases can interact within the
|
||||
trajectory model, deleting an organ/system as a whole is generally more
|
||||
interpretable than summing single-disease attributions.
|
||||
|
||||
\subsection{Historical Counts Are Not Model-Derived Burden}
|
||||
|
||||
One may count observed historical diseases:
|
||||
\[
|
||||
@@ -148,7 +170,7 @@ model and should not be presented as a model-derived disease burden score.
|
||||
Without disease severity labels or disease weights, it treats all disease
|
||||
tokens equally.
|
||||
|
||||
\subsection{What the current model does not estimate}
|
||||
\subsection{What the Current Model Does Not Estimate}
|
||||
|
||||
The current model does not directly estimate:
|
||||
\begin{itemize}[leftmargin=1.5em]
|
||||
@@ -164,7 +186,7 @@ These interpretations require additional labels, mappings, weights, or model
|
||||
training objectives. Using the present all-future model to claim these
|
||||
quantities would be over-interpretation.
|
||||
|
||||
\subsection{Post-onset prognosis for the same new disease}
|
||||
\subsection{Post-Onset Prognosis for the Same New Disease}
|
||||
|
||||
For a disease \(d\) that newly occurs at time \(T_{i,d}\), the model cannot
|
||||
infer the clinical severity of that disease itself. However, after the disease
|
||||
@@ -180,7 +202,7 @@ be followed by different future disease and mortality risk profiles in people
|
||||
with different prior trajectories. It should not be described as direct disease
|
||||
severity.
|
||||
|
||||
\subsection{Future extension with reliable recurrence data}
|
||||
\subsection{Future Extension with Reliable Recurrence Data}
|
||||
|
||||
The above interpretation is constrained by the first-occurrence nature of the
|
||||
current disease sequence. UK Biobank does not provide a reliable longitudinal
|
||||
@@ -228,8 +250,8 @@ all-future 模型产生
|
||||
\[
|
||||
h_i(t)=f_\theta(\mathcal{H}_i(t)),
|
||||
\]
|
||||
并且对模型疾病词表 \(\mathcal{D}\) 中的每个疾病 \(d\),估计未来 \(\tau\) 年内的首次
|
||||
发生风险:
|
||||
并且对模型疾病词表 \(\mathcal{D}\) 中的每个疾病 \(d\),估计未来 \(\tau\) 年内的
|
||||
首次发生风险:
|
||||
\[
|
||||
p_{i,d}(t,\tau)
|
||||
=
|
||||
@@ -248,23 +270,23 @@ all-future 模型产生
|
||||
\]
|
||||
这个历史发生指示量不是模型学出来的,而是直接从事件历史中读出的。
|
||||
|
||||
\subsection{已经发生疾病的 mask}
|
||||
\subsection{已经发生疾病的 Mask}
|
||||
|
||||
如果某个疾病在 \(t\) 之前或 \(t\) 时已经发生,那么该疾病对应的模型输出不应解释为复发
|
||||
风险,也不应解释为当前疾病活跃程度。在汇总未来新发疾病风险时,应对已经发生过的疾病
|
||||
风险,也不应解释为当前疾病活动程度。在汇总未来新发疾病风险时,应对已经发生过的疾病
|
||||
进行 mask:
|
||||
\[
|
||||
p^{\mathrm{new}}_{i,d}(t,\tau)
|
||||
=
|
||||
\left[1-m_{i,d}(t)\right]p_{i,d}(t,\tau).
|
||||
[1-m_{i,d}(t)]p_{i,d}(t,\tau).
|
||||
\]
|
||||
|
||||
\subsection{当前模型直接支持的派生量}
|
||||
\subsection{当前模型直接支持的量}
|
||||
|
||||
当前模型直接支持以下几类量。
|
||||
|
||||
\paragraph{疾病层面的未来首次发生风险。}
|
||||
对每个模型内疾病 \(d\),
|
||||
对每一个模型内疾病 \(d\),
|
||||
\[
|
||||
p^{\mathrm{new}}_{i,d}(t,\tau)
|
||||
\]
|
||||
@@ -277,38 +299,57 @@ all-future 模型产生
|
||||
表示未来 \(\tau\) 年内死亡的概率。死亡是终末结局,不应作为普通疾病负担权重加入疾病
|
||||
负担求和。
|
||||
|
||||
\paragraph{未来无新病且存活的概率。}
|
||||
利用疾病层面风险和死亡风险,可以汇总未来 \(\tau\) 年内无任何模型内新病且存活的概率:
|
||||
\paragraph{指定疾病集合内的未来新发风险。}
|
||||
对于任意由分析者预先指定的疾病 token 集合 \(G\subseteq\mathcal{D}\),模型可以汇总该
|
||||
集合内的未来新发风险:
|
||||
\[
|
||||
S^{\mathrm{all}}_i(t,\tau)
|
||||
R^G_i(t,\tau)
|
||||
=
|
||||
\left[1-p_{i,\mathrm{death}}(t,\tau)\right]
|
||||
\prod_{d\in\mathcal{D}}
|
||||
\left[1-p^{\mathrm{new}}_{i,d}(t,\tau)\right].
|
||||
1-\prod_{d\in G}\left[1-p^{\mathrm{new}}_{i,d}(t,\tau)\right].
|
||||
\]
|
||||
如果用累计 hazard 表示,令
|
||||
\(\Lambda_{i,d}(t,\tau)=-\log[1-p_{i,d}(t,\tau)]\),则
|
||||
这个量回答的是:模型估计该个体在未来 \(\tau\) 年内,至少新发生一个 \(G\) 中尚未发生
|
||||
疾病的概率是多少。它不包含死亡;死亡风险应单独报告为
|
||||
\(p_{i,\mathrm{death}}(t,\tau)\)。
|
||||
|
||||
如果将 \(G\) 称为某个器官系统,那么疾病到器官的分组来自模型外部,不应表述为模型
|
||||
学到的器官评分。
|
||||
|
||||
\subsection{死亡风险预测的模型归因}
|
||||
|
||||
模型还可以用于计算历史疾病集合对死亡风险预测的模型内部归因。对于疾病集合 \(G\),
|
||||
令原始死亡风险为
|
||||
\[
|
||||
S^{\mathrm{all}}_i(t,\tau)
|
||||
p_{i,\mathrm{death}}^{\mathrm{orig}}(t,\tau),
|
||||
\]
|
||||
将输入历史中属于 \(G\) 的历史疾病 token 删除后,再次查询模型,得到
|
||||
\[
|
||||
p_{i,\mathrm{death}}^{(-G)}(t,\tau).
|
||||
\]
|
||||
在概率尺度上,归因可以写为
|
||||
\[
|
||||
\Delta p^G_i(t,\tau)
|
||||
=
|
||||
\exp\left(
|
||||
-\Lambda_{i,\mathrm{death}}(t,\tau)
|
||||
-\sum_{d\in\mathcal{D}}
|
||||
[1-m_{i,d}(t)]\Lambda_{i,d}(t,\tau)
|
||||
\right).
|
||||
p_{i,\mathrm{death}}^{\mathrm{orig}}(t,\tau)
|
||||
-
|
||||
p_{i,\mathrm{death}}^{(-G)}(t,\tau).
|
||||
\]
|
||||
更推荐的主尺度是累计 hazard:
|
||||
\[
|
||||
\Lambda_{i,\mathrm{death}}(t,\tau)
|
||||
=
|
||||
-\log\left[1-p_{i,\mathrm{death}}(t,\tau)\right],
|
||||
\]
|
||||
\[
|
||||
\Delta \Lambda^G_i(t,\tau)
|
||||
=
|
||||
\Lambda_{i,\mathrm{death}}^{\mathrm{orig}}(t,\tau)
|
||||
-
|
||||
\Lambda_{i,\mathrm{death}}^{(-G)}(t,\tau).
|
||||
\]
|
||||
|
||||
\paragraph{未来无指定疾病集合新发且存活的概率。}
|
||||
对于任意由分析者预先指定的疾病 token 集合 \(G\subseteq\mathcal{D}\),可以定义
|
||||
\[
|
||||
S^{G}_i(t,\tau)
|
||||
=
|
||||
\left[1-p_{i,\mathrm{death}}(t,\tau)\right]
|
||||
\prod_{d\in G}
|
||||
\left[1-p^{\mathrm{new}}_{i,d}(t,\tau)\right].
|
||||
\]
|
||||
这只是指定疾病集合层面的未来 disease-free survival 汇总。如果将 \(G\) 称为某个器官系统,
|
||||
那么疾病到器官的分组来自模型外部,不能描述为模型学到的器官评分。
|
||||
这个量应表述为疾病集合对死亡风险预测的模型归因。它不是因果贡献,不是器官损伤评分,
|
||||
也不是临床疾病负担权重。由于轨迹模型中疾病之间可能存在交互,整体删除一个器官系统
|
||||
通常比逐个疾病归因后相加更容易解释。
|
||||
|
||||
\subsection{历史计数不是模型派生的疾病负担}
|
||||
|
||||
@@ -333,8 +374,8 @@ all-future 模型产生
|
||||
\item 不同疾病 token 之间的相对临床重要性。
|
||||
\end{itemize}
|
||||
|
||||
这些解释都需要额外标签、映射、权重或新的训练目标。用当前 all-future 模型直接声称这些量,
|
||||
属于过分解读。
|
||||
这些解释都需要额外标签、映射、权重或新的训练目标。用当前 all-future 模型直接声称
|
||||
这些量,属于过分解读。
|
||||
|
||||
\subsection{同一新发疾病后的预后差异}
|
||||
|
||||
@@ -373,21 +414,25 @@ all-future 模型产生
|
||||
\item 复发或重复事件风险:疾病已经发生后的未来 episode 风险;
|
||||
\item 死亡风险:与非致死事件竞争的终末结局风险。
|
||||
\end{itemize}
|
||||
如果复发 episode 还带有可靠的 episode 层面严重程度标签,例如住院强度、治疗升级或经过
|
||||
验证的严重程度分级,那么还可以进一步训练有监督的严重程度相关预后模型。但这些扩展都
|
||||
需要新的数据和新的训练目标,并不是当前 all-future first-occurrence 模型已经具备的能力。
|
||||
如果复发 episode 还带有可靠的 episode 层面严重程度标签,例如住院强度、治疗升级或
|
||||
经过验证的严重程度分级,那么还可以进一步训练有监督的严重程度相关预后模型。但这些
|
||||
扩展都需要新的数据和新的训练目标,并不是当前 all-future first-occurrence 模型已经
|
||||
具备的能力。
|
||||
|
||||
\section{Recommended wording}
|
||||
\section{Recommended Wording}
|
||||
|
||||
\paragraph{English.}
|
||||
The all-future model is a history-conditioned incident disease and mortality
|
||||
risk model. Its outputs support future disease-free survival summaries over the
|
||||
modeled disease vocabulary, but do not directly quantify current disease
|
||||
burden, organ damage, frailty, or disease severity.
|
||||
risk model. Its outputs support separate reporting of future mortality risk and
|
||||
future incident disease risk over analyst-specified disease sets. Historical
|
||||
disease sets may be ablated to obtain model attribution to predicted mortality
|
||||
risk, but this is not causal contribution and does not directly quantify current
|
||||
disease burden, organ damage, frailty, or disease severity.
|
||||
|
||||
\paragraph{中文。}
|
||||
all-future 模型是基于既往轨迹的未来新发疾病和死亡风险模型。它的输出可以支持模型词表
|
||||
范围内的未来无新病且存活概率汇总,但不能直接量化当前疾病负担、器官损伤、衰弱程度或
|
||||
疾病严重度。
|
||||
all-future 模型是基于既往轨迹的未来新发疾病和死亡风险模型。它的输出可以支持分别
|
||||
报告未来死亡风险,以及指定疾病集合内的未来新发疾病风险。通过删除历史疾病集合可以
|
||||
得到其对死亡风险预测的模型归因,但这不是因果贡献,也不能直接量化当前疾病负担、
|
||||
器官损伤、衰弱程度或疾病严重度。
|
||||
|
||||
\end{document}
|
||||
|
||||
Reference in New Issue
Block a user